Aclaris Therapeutics Inc (NASDAQ:ACRS) currently has a daily average trading volume of 881.55K but it saw 1061781 shares traded in last market. With a market cap of 141.85M USD, the company’s current market price of $1.31 came rising about 4.80 while comparing to the previous closing price of $1.25. In past 52 weeks, the stock remained buoying in the range of price level as high as $5.17 and as low as $0.95.
Taking a look at 20-day trading activity of Aclaris Therapeutics Inc (ACRS) gives us an average price of $1.2420, while its current price level is -74.66% below from 52-week high level whereas it is 37.68% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.4696 while that of 200 days or SMA-200 reads an average of $1.9062. A closer look into the stock’s movement over the week reveals that its volatility is standing at 7.99% during that period while stretching the period over a month that increases to 8.49%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 46.98 which implies that the stock is in neutral territory.
H.C. Wainwright upgraded its recommendation for the stock as a “Buy” from “Neutral” on December 23, 2024 while assigning a price target of $20.
Over the week, ACRS’s stock price is moving -5.07% down while it is 6.50% when we observe its performance for the past one month.
Currently, Aclaris Therapeutics Inc’s total number of outstanding shares is 108.27M with 2.66% of that held by the insiders while 86.13% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -83.76% and return on equity (ROE) at -84.46%. Stock’s beta reads 0.44. Stock has a price to book (P/B) ratio of 0.98 while price to sale or P/S ratio amounts to 7.98. Its return on asset (ROA) is -62.91% on average.
